375 related articles for article (PubMed ID: 26353592)
1. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled ultra-small Fe
Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.
Wu T; Ding X; Su B; Soodeen-Lalloo AK; Zhang L; Shi JY
Clin Transl Oncol; 2018 May; 20(5):599-606. PubMed ID: 28956266
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.
Liu C; Liu DB; Long GX; Wang JF; Mei Q; Hu GY; Qiu H; Hu GQ
Chin Med J (Engl); 2013 Jun; 126(12):2242-7. PubMed ID: 23786932
[TBL] [Abstract][Full Text] [Related]
5. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Zhang C; Jugold M; Woenne EC; Lammers T; Morgenstern B; Mueller MM; Zentgraf H; Bock M; Eisenhut M; Semmler W; Kiessling F
Cancer Res; 2007 Feb; 67(4):1555-62. PubMed ID: 17308094
[TBL] [Abstract][Full Text] [Related]
6. Micro-CT molecular imaging of tumor angiogenesis using a magnetite nano-cluster probe.
Liu P; Li J; Zhang C; Xu LX
J Biomed Nanotechnol; 2013 Jun; 9(6):1041-9. PubMed ID: 23858968
[TBL] [Abstract][Full Text] [Related]
7. A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes.
Liu Y; Yang Y; Zhang C
Int J Nanomedicine; 2013; 8():1083-93. PubMed ID: 23515638
[TBL] [Abstract][Full Text] [Related]
8. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
9. Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe.
Chen L; Xie J; Wu H; Zang F; Ma M; Hua Z; Gu N; Zhang Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():339-346. PubMed ID: 29100127
[TBL] [Abstract][Full Text] [Related]
10. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
[TBL] [Abstract][Full Text] [Related]
11. Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging.
Yang Y; Zhang L; Cai J; Li X; Cheng D; Su H; Zhang J; Liu S; Shi H; Zhang Y; Zhang C
ACS Appl Mater Interfaces; 2016 Jan; 8(3):1718-32. PubMed ID: 26731347
[TBL] [Abstract][Full Text] [Related]
12. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
13. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
14. Mono-dispersed high magnetic resonance sensitive magnetite nanocluster probe for detection of nascent tumors by magnetic resonance molecular imaging.
Zhang C; Xie X; Liang S; Li M; Liu Y; Gu H
Nanomedicine; 2012 Aug; 8(6):996-1006. PubMed ID: 22197723
[TBL] [Abstract][Full Text] [Related]
15. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
[TBL] [Abstract][Full Text] [Related]
16. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
[TBL] [Abstract][Full Text] [Related]
17. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
[TBL] [Abstract][Full Text] [Related]
18. Targeting T1 and T2 dual modality enhanced magnetic resonance imaging of tumor vascular endothelial cells based on peptides-conjugated manganese ferrite nanomicelles.
Gong M; Yang H; Zhang S; Yang Y; Zhang D; Li Z; Zou L
Int J Nanomedicine; 2016; 11():4051-63. PubMed ID: 27578974
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.
Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA
Contrast Media Mol Imaging; 2015; 10(3):225-36. PubMed ID: 25327822
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.
Lijowski M; Caruthers S; Hu G; Zhang H; Scott MJ; Williams T; Erpelding T; Schmieder AH; Kiefer G; Gulyas G; Athey PS; Gaffney PJ; Wickline SA; Lanza GM
Invest Radiol; 2009 Jan; 44(1):15-22. PubMed ID: 18836386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
